About Us

Introducing IMG-AbS™

ImmunoGenes' patented technology platform IMG-AbS™, is an FcRn technology using genetically modified animals that overexpress the neonatal Fc Receptor (FcRn). Because of FcRn's role in antigen presentation, the company's animals are able to mount a strong immune response against weakly immunogenic targets.

Learn More

Contact

EUROPE

Switzerland
ImmunoGenes AG
Gotthardstrasse 28
CH-6304 Zug

Hungary
ImmunoGenes Kft
Hunor utca 20/A
2092 Budakeszi, Hungary
T: +36-30-757-7870
F: +36-23-455-202

 

UNITED STATES

325 West End Avenue
New York, NY 10023
T: +1-917-327-6423

 

Email Us

info@immunogenes.com

Custom Antibody Service
antibody@immunogenes.com

Custom Transgenic Service
transgenics@immunogenes.com